Voyager Therapeutics And Neurocrine Biosciences Have Selected Lead Development Candidate In GBA1 Gene Therapy Program For Potential Treatment Of Parkinson's Disease And Other GBA1-mediated Diseases
Voyager Therapeutics和Neurocrine Biosciences已在GBA1基因疗法项目中选出了潜在的帕金森氏病和其他GBA1介导疾病的潜在治疗药物的潜在开发候选人